Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inflazyme issued U.S. patent for potential asthma compounds

April 27, 2000

Preparation, activity and use of inhibitors of Th2-type cytokine production described by Sumitomo

April 24, 2000

Novel compounds that inhibit hematopoietic cell activation in development at AstraZeneca

April 24, 2000

Azabicyclic compounds as modulators of cell adhesion

April 20, 2000

Antihistamines reported useful by Schering-Plough for Rx of sinusitis and otitis media

April 20, 2000

Expired air from asthmatic subjects has unusually low pH

April 20, 2000

Lilly and Ono to collaborate on ARDS therapeutic

April 18, 2000

Celecoxib: use in inflammatory conditions of the head and neck

April 18, 2000

News from FASEB: TBC-1269 mechanism-of-action studies described

April 17, 2000

Inhibitors of IL-5 production synthesized by Janssen

April 17, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...